Literature DB >> 6499626

Immunological findings in whole and parotid saliva of patients with Crohn's disease and healthy controls.

G Crama-Bohbouth, P Lems-van Kan, I T Weterman, I Biemond, A S Peña.   

Abstract

Since oral lesions appear to occur more commonly in patients with Crohn's disease (CD) than in normal controls or patients with ulcerative colitis, it has been suggested that a deficit of locally produced IgA allows the invasion of the oral mucous membrane by antigens and contributes to the production of oral lesions. In connection with this hypothesis, the concentrations of IgA, IgM, and IgG in whole and parotid saliva were investigated by the ELISA technique in 20 patients with CD and 20 healthy subjects matched for dental status. IgA predominated in whole and parotid saliva in both patients and controls, and in both groups whole saliva had higher levels of IgA, IgM, and IgG than parotid saliva did. Compared with the controls, IgA, IgM, and IgG levels were significantly elevated in the whole saliva of CD patients. However, no correlation was found between immunoglobulin levels and age, sex, therapy, duration, localization, or activity of the disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6499626     DOI: 10.1007/bf01317081

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  Oral manifestations of Crohn's disease.

Authors:  P Asquith; R A Thompson; W T Cooke
Journal:  Gut       Date:  1975-04       Impact factor: 23.059

2.  Device for collection of human parotid saliva.

Authors:  W A CURBY
Journal:  J Lab Clin Med       Date:  1953-03

3.  Immunohistological findings in lip biopsy specimens from patients with Crohn's disease and healthy subjects.

Authors:  G Crama-Bohbouth; F T Bosman; B J Vermeer; A M van der Wal; I Biemond; I T Weterman; A S Peńa
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

4.  ELISA assay for quantitative measurement of human immunoglobulins IgA, IgG, and IgM in nanograms.

Authors:  P Lems-Van Kan; H W Verspaget; A S Peña
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

Review 5.  Mucosal immunology.

Authors:  J Bienenstock; A D Befus
Journal:  Immunology       Date:  1980-10       Impact factor: 7.397

6.  Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding.

Authors:  L K Richman; A S Graeff; R Yarchoan; W Strober
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

7.  Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI).

Authors:  W R Best; J M Becktel; J W Singleton
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

  7 in total
  5 in total

1.  Immunological study of histologically non-involved jejunum during Crohn's disease: evidence for reduced in vivo secretion of secretory IgA.

Authors:  P Marteau; J F Colombel; J Nemeth; J P Vaerman; J C Dive; J C Rambaud
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

Review 2.  The aetiology of Crohn's disease.

Authors:  G N Tytgat; C J Mulder
Journal:  Int J Colorectal Dis       Date:  1986-07       Impact factor: 2.571

3.  Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease.

Authors:  N W Savage; K Barnard; P J Shirlaw; D Rahman; M Mistry; M P Escudier; J D Sanderson; S J Challacombe
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

4.  Salivary anti-nuclear antibody (ANA) mirrors serum ANA in systemic lupus erythematosus.

Authors:  Ting Zhang; Yong Du; Qingqing Wu; Hao Li; Thao Nguyen; Gabriel Gidley; Valeria Duran; Daniel Goldman; Michelle Petri; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2022-01-03       Impact factor: 5.156

Review 5.  Salivary Stress/Immunological Markers in Crohn's Disease and Ulcerative Colitis.

Authors:  Alberto Finamore; Ilaria Peluso; Omar Cauli
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.